IndustryCompany release

Roche nine-month sales up 6% at constant rates; 2026 outlook confirmed

Roche · Thu 22 Oct 2026

Roche reports Group sales of CHF 46.5 billion for the first nine months, led by Pharmaceuticals, alongside a run of US FDA approvals, Priority Reviews and a diagnostics clearance.

Roche said on 22 October 2026 that Group sales rose 6% at constant exchange rates over the first nine months of the year, reaching CHF 46.5 billion. In Swiss francs, growth was 1%. The company confirmed its outlook for 2026.

By division, Pharmaceuticals sales grew 7% and Diagnostics 4%, both at constant exchange rates. Roche named Xolair, Hemlibra, Ocrevus, Phesgo and Vabysmo as the main growth drivers in the pharmaceuticals business.

On the regulatory side, Roche listed US FDA approvals for Tecentriq, Gazyva and Enspryng, the last in thyroid eye disease. The agency also granted Priority Review to fenebrutinib and to Enspryng. Priority Review is an FDA designation that sets a shorter target timeline for a decision on an application.

In diagnostics, the FDA cleared the Elecsys pTau217 blood test for Alzheimer's disease. The summary available does not give further details on indications, filing dates or the quarterly breakdown.

What it means for your team

  • Market-access teams should note that the main growth products are established brands, such as Xolair, Hemlibra, Ocrevus, Phesgo and Vabysmo, rather than new launches.
  • Regulatory teams can track the Priority Review designations for fenebrutinib and Enspryng, which imply compressed FDA review timelines.
  • The FDA clearance of the Elecsys pTau217 test adds a blood-based option to Alzheimer's diagnostics, relevant to diagnostic pathway and reimbursement planning.
  • The gap between 6% growth at constant rates and 1% in Swiss francs shows the currency effect on reported results.

Company's press release: Roche ↗

Article written by VigiEye from the official source (Roche). Claims are the company's own. AI-assisted; check the source before acting.

More Industry All →